Uncovering cellular mechanisms of genetic skin diseases

Northwestern Medicine investigators have discovered a novel mechanism linking an intercellular adhesion molecule with genetic inflammatory skin diseases, according to findings published in the Journal of Clinical Investigation. The study, led by Kathleen Green, Ph.D., the Joseph L. Mayberry, Sr., Professor of Pathology and Toxicology and a professor of Dermatology, suggests that Desmoglein-1 (Dsg1) deficiency […]

Dengue virus makes mosquitos bite more often to better transmit disease

Software-analyzed high-resolution videos have revealed that dengue-infected mosquitos are more attracted to mammals and bite more often, tripling disease transmission opportunities. Publishing in the journal Proceedings of the National Academy of Sciences (PNAS), the research team from Duke-NUS Medical School, the French Research Institute for Sustainable Development (IRD), the University of Montpellier, France, and other […]

Pandemic Weighing on Docs’ Happiness Outside of Work: Survey

One of the unexpected consequences of the pandemic is that many people are rethinking their priorities and lifestyles, and physicians are no exception. This year’s Medscape Physician Lifestyle and Happiness Report surveyed more than 10,000 physicians in 29 specialties about how they are prioritizing wellness, work-life balance, and their family lives during this challenging time. […]

Depression up in pediatric, adult hidradenitis suppurativa patients

(HealthDay)—The prevalence of depression is increased among pediatric and adult patients with hidradenitis suppurativa (HS), according to a study published in the January issue of the Journal of the American Academy of Dermatology. Shari Wright, from the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, New York, and colleagues compared the prevalence […]

ACIP Releases New Dengue Vaccine Recommendations

The CDC’s Advisory Committee on Immunization Practices (ACIP) has now recommended using Sanofi’s dengue vaccine, Dengvaxia, in the US, with specific restrictions. The vaccine is only to be used for children aged 9–16 who live in endemic areas and who have evidence with a specific diagnostic test of prior dengue infection. Dengue is a mosquito-borne […]